Grant - Neurodon
Investment Firm
Overview
Neurodon is a biopharmaceutical company with small molecules in IND-enabling studies for type 1 and type 2 diabetes and Alzheimer's disease.
Announced Date
Oct 03, 2023
Funding Type
Grant
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Neurodon raised $2900000 on 2023-10-03 in Grant
Neurodon is a biopharmaceutical company with small molecules in IND-enabling studies for type 1 and type 2 diabetes and Alzheimer's disease.
Company Funding History
11
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 01, 2023 |  Angel Round - Neurodon | - | 2.0M | |
| Jun 03, 2022 | Grant - Neurodon | 1 | - | 920.0K |
| Aug 14, 2018 | Grant - Neurodon | 1 | - | 275.0K |
| Nov 14, 2014 | Equity Crowdfunding - Neurodon | - | undefined |
Recent Activity
There is no recent news or activity for this profile.